Products (AnaConDa)


Operating Conditions

Description
Disposable product: Single patient, 24 hours use
Anaesthetic agents: Isoflurane or Sevoflurane
Efficiency: Normally > 90% is reflected.
Depending on Minute Volume
Dosing: Depending on clinical needs.
(See Table 1a)
Tidal volume working range: Minimum 350 ml
Resistance to gas flow @ 60 L/min: 2.5 cm H2O (250 Pa)
Moisture loss at 0.75 l x 12 breaths/min: 5 mg/l
Corresponding moisture output: 30 mg H2O/l
Moisture loss at 1.0 l x 10 breaths/min: 7 mg/l
Corresponding moisture output: 29 mg H2O/l
Bacterial filtration: 99.999%
Viral filtration: 99.98%
Dead space: Approx. 100 ml
Connectors: 15M/22M-15F
Weight: 50 g
Gas sampling port: Female luer lock
Agent supply line: 2200 mm

AnaConDa

Ref: 26100


Product Description

AnaConDa is a disposable medical device which enables the administration of volatile anaesthetics (Isoflurane or Sevoflurane) and is connected between the Y-piece and ET-tube. The device has no electrical components and is MRI & CT scan compatible. It also acts as an excellent HME and contains an electrostatic bacterial/viral filter. This version has a dead space of 100ml and can function with tidal volumes as low as 350ml.

  • Reference Number: 26100
  • Use: Single Patient, 24 hour use
  • Device Classification: Class IIa
  • Shelf Life: 5 Years from Date of Manufacturing
  • Disposal: Normal hospital waste
  • Minimum Order Quantity: 12 Units

Dosage

Dosing is based on individual patient clinical requirements and is guided by clinical evaluation and reading of the Fet/MAC value on the gas monitor. The syringe pump rate is determined by the minute volume, end tidal concentration (Fet) or MAC requirements and the clinical needs of the patient. The following syringe pump rates are typical for Isoflurane or Sevoflurane.

Table 1a

Volatile
Agent
Expected
Pump Rates
Resulting
Fet Values
Isoflurane 2-7 ml/hr 0,2-0,7 %
Sevoflurane 4-10 ml/hr 0,5-1,4 %

This table gives is an approximate pump rate and concentration guide, other pump rates and concentrations can be achieved depending on clinical needs.

There is a higher patient uptake of the volatile during the first 10-30 minutes (Induction Phase) of administration. Adjustments to the pump rate will need to be made according to the measured end tidal concentration (Fet) or MAC and the clinical needs of the patient.

Please refer to “Instructions for Use” for more information.